International Business Machines (NYSE: IBM) shares rose after UBS Group upgraded the company from a sell to a neutral rating. UBS established a new price target of $236.00 for the technology firm. This positive momentum follows a significant share price decline earlier in the week caused by the launch of a competitive AI tool from startup Anthropic.
IBM also secured a five-year contract with the Defense Commissary Agency (DeCA) worth up to $112 million. The company will modernize electronic shelf label systems in military commissaries worldwide. This initiative focuses on improving pricing accuracy and increasing operational efficiency.
Market analysts suggested the recent sell-off was an overreaction and presented a buying opportunity. These combined developments helped restore investor confidence in the company’s market position.